Skip to main content

FGFR Kinase Inhibitors

FGFR kinase inhibitors are used to treat a variety of cancers. They work by preventing fibroblast growth factor receptor (FGFR) signaling to slow cancer cell growth.

Why are fgfr kinase inhibitors prescribed?

  1. Bile Duct Cancer (33%)
  2. Liver Cancer (33%)
  3. Bladder Cancer (33%)
Prices for popular FGFR Kinase Inhibitors medications
Viewing 3 of 3 medications
tablet icon

Lytgobi

as low as$5,205
FUTIBATINIB treats bile duct cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
ERDAFITINIB treats bladder cancer and kidney cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
PEMIGATINIB treats bile duct cancer. It may also be used to treat a type of bone marrow cancer (myeloid/lymphoid neoplasm). It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.